Bladder Meridian Gua Sha for Lumbar Disc Herniation: Efficacy and CRP Regulation Via Cutaneous-Meridian-Visceral Axis in Shen Period

Completed · Not applicable

Conditions studied: Lumbar Disc Herniation

In brief

Based on the "Cutaneous Region-Meridian-Visceral" axis theory, in this study, we investigated clinical efficacy of the Gua Sha intervention on the Bladder Meridian during the Shen Period (3:00-5:00 p.m.) for lumbar disc herniation (LDH) and its regulatory effect on serum C-reactive protein (CRP).This randomized controlled study enrolled 128patients with LDH admitted to the Department of Rehabilitation at Guangdong Hospital of Integrated Traditional Chinese and Western Medicine between January 2023 and December 2024. They were randomly assigned to a control group (n=64) and an observation group (n=64). The control group consisted of standard treatment and care according to the diagnostic and treatment guidelines for LDH. The observation group consisted of standard treatment and care supplemented with Gua Sha on the Bladder Meridian during the Shen Period. The Japanese Orthopedic Association (JOA) scores, Visual Analog Scale (VAS) pain scores, changes in CRP levels, and traditional Chinese medicine (TCM) efficacy evaluations were assessed for both groups before the intervention and at 2-week and 4-week after the intervention.

Key facts

Study ID

NCT07754422

Run by

Guangdong Provincial Hospital of Traditional Chinese Medicine

People needed

128

Starts

2023-01-17

Expected to finish

2024-12-30

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients meeting the diagnostic criteria for LDH according to Traditional Chinese Medicine and Western Medicine
• Stable vital signs and absence of severe complications, including concomitant severe cardiovascular, cerebrovascular, hepatic, renal, or hematological diseases
• Patients able to cooperate with the entire course of treatment and sign an informed consent form
• Patients unsuitable for surgery and experiencing recurrent episodes following treatment
• Exclusion Criteria：
• Participants unable to continue treatment
• Participants developing other serious illnesses during the trial
• Participants whose symptoms worsen to the point that emergency measures are required

Where it is running

• Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine — Foshan, GuanDongSheng, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.